Sexually Transmitted Infections (Not HIV or Hepatitis)
11
2
2
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (11)
IMARA for Black Male Caregivers and Girls Empowerment (IMAGE)
Sexual Health Access at Retail Pharmacies: Advancing Pharmacy-based Delivery of Primary STI and HIV Prevention for Cisgender Women
Developing an HIV Disclosure Intervention for Men in Uganda
Genital Tract Infections, the Vaginal Microbiome and Gestational Age at Birth Among Pregnant Women in South Africa
Acceptability, Feasibility, and Preliminary Impact of a Web-based, HIV Prevention Toolkit With Cisgender Male Couples in Lima, Peru
Improving Perinatal Outcomes Among Kenyan Pregnant Women With an Integrated STI Testing Model
Assess the Performance of Metagenomic Sequencing in the Diagnosis of STI (NGS-IST)
Kentucky Communities and Researchers Engaging to Halt the Opioid Epidemic (CARE2HOPE)
AllyQuest Adherence App Intervention for HIV-positive Men Who Have Sex With Men and Transgender Women: Pilot Trial
Overcoming Geography With Technology: Medical Drones Project
Personalized HIV and STI Testing Tool